secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0001437749-25-008671
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma files for Chapter 7 bankruptcy; board and officers depart
---------------------------------------------------------------------------

- Filed voluntary Chapter 7 bankruptcy petition on March 21, 2025 in Delaware Bankruptcy Court.
- Chapter 7 trustee to be appointed to administer and possibly liquidate company assets.
- All four board members (Pietro Bersani, Michael Nagel, Mike Catlin, Pamela Misajon) resigned effective immediately.
- Terminated CFO Brian Hungerford, COO Leonardo Mirandola, and Chief of Staff Scott Dahlbeck on March 21, 2025.
- Board has zero members following resignations; control passes to trustee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000143774925008671/0001437749-25-008671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000143774925008671/krbp20250321_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-008671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer